J Cardiovasc Ultrasound.  2015 Sep;23(3):193-194. 10.4250/jcu.2015.23.3.193.

What Did Happen during the Device Closure of the Patent Foramen Ovale?

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, School of Medicine, Chungnam National University, Daejeon, Korea. jaehpark@cnu.ac.kr
  • 2Department of Neurology, Chungnam National University Hospital, School of Medicine, Chungnam National University, Daejeon, Korea.
  • 3Department of Cardiovascular Surgery, Chungnam National University Hospital, School of Medicine, Chungnam National University, Daejeon, Korea.

Abstract

No abstract available.

Keyword

Patent foramen ovale; Device closure; Thrombus; Complication

MeSH Terms

Foramen Ovale, Patent*
Thrombosis

Figure

  • Fig. 1 Transesophageal echocardiographic examination shows about a 13 cm sized linear mass (arrowheads) attached on the tip of the Amplatzer® PFO occlude device (arrow).

  • Fig. 2 After the open heart surgery, about 20 cm sized fresh thrombus (arrowheads) is attached on the removed device (arrow).


Reference

1. Wolfrum M, Froehlich GM, Knapp G, Casaubon LK, DiNicolantonio JJ, Lansky AJ, Meier P. Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis. Heart. 2014; 100:389–395.
2. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation. 2002; 105:2845–2848.
Full Text Links
  • JCU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr